Russia's Sputnik Light vaccine approved for use in Mauritius - RDIF

Vials labeled Sputnik V coronavirus disease (COVID-19) vaccine
Vials labeled "Sputnik V coronavirus disease (COVID-19) vaccine", March 24, 2021. REUTERS / Dado Ruvic/File Photo

MOSCOW, June 2 (Reuters) - Russia's single-dose Sputnik Light vaccine against COVID-19 has been approved for use in Mauritius, Russia's RDIF sovereign wealth fund, which markets the shot internationally, said on Wednesday.

Reporting by Alexander Marrow; Editing by Maria Kiselyova

Our Standards: The Thomson Reuters Trust Principles.